The document discusses the importance of monitoring elemental impurities in pharmaceuticals, detailing regulatory compliance and specific guidelines for acceptable limits of various trace metals using ICP-MS (Inductively Coupled Plasma Mass Spectrometry). It outlines the principles of ICP-MS, including sample preparation and ionization techniques, and compares different analytical methods, highlighting advantages and limitations. The conclusion emphasizes ICP-MS as a highly effective technique for achieving low detection limits and high productivity in elemental analysis.